Eli Lilly (Painful Distal Sensory Polyneuropathy): Effect of LY4515100 versus Placebo in Participants with Painful Distal Sensory Polyneuropathy - October 7, 2026
AbbVie Inc., Sanctuary (Alzheimer’s Disease): A Phase 1b/2 Study to Evaluate Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of ABBV-1758 in Subjects with Alzheimer’s Disease - October 7, 2026
Harmony, ONSTRIDE 1 (Narcolepsy): A Phase 3 Efficacy and Safety Study of HBS-301 in Participants with Narcolepsy - September 28, 2026
Alkermes, BRILLIANCE (Narcolepsy Type 2): A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 - September 28, 2026
Alkermes, BRILLIANCE (Narcolepsy Type 1): A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 - September 21, 2026
Sanofi, THESEUS (COPD): Efficacy, safety, and tolerability study of lunsekimig compared with placebo in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype - November 19, 2025
